• The global Nuclear Medicine Isotopes market size was valued at US$ 4.56 billion in 2024 and is projected to reach US$ 7.23 billion by 2030, at a CAGR of 8.0% during the forecast period 2024-2030.
• The United States Nuclear Medicine Isotopes market size was valued at US$ 1.45 billion in 2024 and is projected to reach US$ 2.23 billion by 2030, at a CAGR of 7.4% during the forecast period 2024-2030.
Email: help@24marketreports.com +1(917)-997-2424
• The global Nuclear Medicine Isotopes market is growing rapidly, driven by increasing cancer treatment needs and diagnostic applications. In 2023, total production value reached US$ 4.2 billion, with diagnostic applications accounting for 65% of demand. The therapeutic isotopes segment is the fastest-growing at 9.5% annually. The market saw a 30% increase in demand for novel therapeutic isotopes in 2023, reflecting advances in targeted therapy. Diagnostic isotopes dominate with a 70% market share, while therapeutic isotopes are growing at 10% annually. North America leads with a 45% market share, while Asia Pacific is the fastest-growing region at 8.8% CAGR. The industry is focusing on developing new production methods, with a 35% growth in R&D investments for supply chain reliability.
Email: help@24marketreports.com
+1(917)-997-2424
